Price:
Rs. 10,070.00
Sample Type: PURE CULTURE
Fasting Not Requierd
Booking Procedure:
- Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
- Soft copy reports will be sent to your email address within 24 to 48 hours.
Frequently Asked Questions (FAQ's):
What does the AFB Drug Susceptibility Panel include?
This Metropolis Healthcare test evaluates a pure culture of Mycobacterium tuberculosis against 10 key first-line and second-line anti-TB drugs to detect resistance and guide proper treatment.
Why choose Metropolis Healthcare for this TB drug sensitivity test?
Metropolis Healthcare provides advanced TB diagnostics, specialized mycobacteriology labs, expert microbiologists, and highly reliable drug-susceptibility reporting for accurate clinical decision-making.
What sample type is required for this test at Metropolis Healthcare?
A pure culture of the Mycobacterium tuberculosis isolate is needed. This allows Metropolis Healthcare to perform detailed testing of resistance to multiple anti-TB drugs.
Who should consider this test at Metropolis Healthcare?
Patients diagnosed with tuberculosis, those suspected of drug-resistant TB, or individuals not responding to standard TB treatment may need this test to determine the appropriate therapy.
How does Metropolis Healthcare conduct the drug susceptibility testing?
The pure culture undergoes controlled laboratory analysis where each anti-TB drug is evaluated for sensitivity or resistance following standardized Metropolis Healthcare protocols.
How long do results take from Metropolis Healthcare?
Results generally require several days due to the careful incubation and interpretation needed for first- and second-line anti-TB drug susceptibility.
How does this test help in TB management?
The test helps identify multidrug resistance (MDR), extensively drug resistance (XDR), and other resistance patterns, enabling targeted treatment through Metropolis Healthcare’s accurate reporting.
Is this test helpful for monitoring ongoing TB treatment?
Yes. It helps evaluate treatment failures and guides clinicians in adjusting therapy when resistance develops during the course of TB management.